Codiak BioSciences, Inc. Capital Expenditures
Codiak BioSciences, Inc. reported Capital Expenditures of $362.00 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2022-11-03
- Codiak BioSciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-09-30 was $9.00K, a 98.36% decline year-over-year.
- Codiak BioSciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-06-30 was $171.00K, a 79.62% decline year-over-year.
- Codiak BioSciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-03-31 was $182.00K, a 88.07% decline year-over-year.
- Codiak BioSciences, Inc. payments to acquire property, plant, and equipment for the quarter ending 2021-12-31 was $332.00K, a 71.40% decline year-over-year.
- Codiak BioSciences, Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $3.25M, a 84.59% decline from fiscal 2020.
- Codiak BioSciences, Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $21.05M, a 100.95% increase from fiscal 2019.
- Codiak BioSciences, Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $10.48M.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2022-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $180.00K derived: sum of 2 quarters · filed 2022-11-03 | $362.00K 10-Q · filed 2022-11-03 | $694.00K derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | $171.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $353.00K 10-Q · filed 2022-08-04 | $685.00K derived: sum of 3 quarters · filed 2022-08-04 | $1.23M derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-03-31 | $182.00K 10-Q · filed 2022-05-05 | $514.00K derived: sum of 2 quarters · filed 2022-05-05 | $1.06M derived: sum of 3 quarters · filed 2022-11-03 | $1.90M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-12-31 | $332.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $880.00K derived: sum of 2 quarters · filed 2022-11-03 | $1.72M derived: sum of 3 quarters · filed 2022-11-03 | $3.25M 10-K · filed 2022-03-10 |
| 2021-09-30 | $548.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $1.39M derived: sum of 2 quarters · filed 2022-11-03 | $2.91M 10-Q · filed 2022-11-03 | $4.07M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | $839.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $2.37M 10-Q · filed 2022-08-04 | $3.53M derived: sum of 3 quarters · filed 2022-08-04 | $5.33M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $1.53M 10-Q · filed 2022-05-05 | $2.69M derived: sum of 2 quarters · filed 2022-05-05 | $4.49M derived: sum of 3 quarters · filed 2022-05-05 | $8.51M derived: sum of 4 quarters · filed 2022-05-05 |
| 2020-12-31 | $1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $2.97M derived: sum of 2 quarters · filed 2022-03-10 | $6.99M derived: sum of 3 quarters · filed 2022-03-10 | $21.05M 10-K · filed 2022-03-10 |
| 2020-09-30 | $1.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $5.83M derived: sum of 2 quarters · filed 2021-11-04 | $19.89M 10-Q · filed 2021-11-04 | $26.85M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $4.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $18.09M 10-Q · filed 2021-08-05 | $25.04M derived: sum of 3 quarters · filed 2021-08-05 | |
| 2020-03-31 | $14.06M 10-Q · filed 2021-05-06 | $21.02M derived: sum of 2 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $6.96M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $10.48M 10-K · filed 2021-03-17 | ||
| 2019-09-30 | $3.52M 10-Q · filed 2020-11-19 |